Bleeding in louse-borne relapsing fever II. Fibrinolysis following treatment
| Autor: | David A. Warrell, E.H.O. Parry, T. Gabre Kidan, P.L. Perine, A.D.M. Bryceson |
|---|---|
| Rok vydání: | 1971 |
| Předmět: |
Male
medicine.medical_specialty relapsing fever medicine.medical_treatment Hemorrhage Fibrinogen Gastroenterology Fibrin Internal medicine Fibrinolysis medicine Humans Platelet Louse-Borne Relapsing Fever biology business.industry Relapsing Fever Public Health Environmental and Occupational Health General Medicine Heparin Tetracycline medicine.disease Infectious Diseases Immunology biology.protein Parasitology Blood Coagulation Tests business Fibrinolytic agent medicine.drug |
| Zdroj: | Transactions of the Royal Society of Tropical Medicine and Hygiene. 65:782-787 |
| ISSN: | 0035-9203 |
| DOI: | 10.1016/0035-9203(71)90092-7 |
| Popis: | Treatment of louse-borne relapsing fever was followed by a sudden increase in fibrin degradation productions (FDP) in 6 of 7 patients. The FDP were believed to be the result of fibrinolysis secondary to intravascular clotting in 2 patients who also had transient decreases in plasma fibrinogen concentration and platelet count. In the remaining cases, a mixed form of fibrinolysis with elevated circulating fibrinolytic activity and local lysis secondary to intravascular clotting was presumed to be responsible for the elevated FDP. A heparin infusion in 3 patients did not prevent the increase in FDP following treatment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|